4.6 Article

TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy

Related references

Note: Only part of the references are listed.
Review Immunology

Human Tumor-infiltrating Myeloid Cells: Phenotypic and Functional Diversity

Louise A. Elliott et al.

FRONTIERS IN IMMUNOLOGY (2017)

Review Chemistry, Medicinal

Diverse macrophages polarization in tumor microenvironment

Inmoo Rhee

ARCHIVES OF PHARMACAL RESEARCH (2016)

Review Immunology

The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

Vinit Kumar et al.

TRENDS IN IMMUNOLOGY (2016)

Review Multidisciplinary Sciences

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Vincenzo Bronte et al.

NATURE COMMUNICATIONS (2016)

Article Oncology

CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer

Martin Turcotte et al.

CANCER RESEARCH (2015)

Review Oncology

Immune Checkpoint Blockade in Cancer Therapy

Michael A. Postow et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Review Chemistry, Medicinal

Reverse phase protein arrays in signaling pathways: a data integration perspective

Chad J. Creighton et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2015)

Review Biochemistry & Molecular Biology

Signaling pathways involved in MDSC regulation

Prashant Trikha et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)

Editorial Material Oncology

Entering the mainstream of cancer treatment

Steven A. Rosenberg

NATURE REVIEWS CLINICAL ONCOLOGY (2014)

Editorial Material Biotechnology & Applied Microbiology

The immune checkpoint inhibitors: where are we now?

Rachel Webster

NATURE REVIEWS DRUG DISCOVERY (2014)

Article Cell Biology

Polarization and reprogramming of myeloid-derived suppressor cells

Wen-Chin Yang et al.

JOURNAL OF MOLECULAR CELL BIOLOGY (2013)

Review Oncology

Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer

Robert Wesolowski et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2013)

Review Oncology

Combining immunotherapy and targeted therapies in cancer treatment

Matthew Vanneman et al.

NATURE REVIEWS CANCER (2012)

Article Oncology

Cancer Immunotherapy Comes of Age

Suzanne L. Topalian et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Immunology

Epigenetic tethering of AID to the donor switch region during immunoglobulin class switch recombination

Beena Patricia Jeevan-Raj et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2011)

Article Multidisciplinary Sciences

A Simple Hanging Drop Cell Culture Protocol for Generation of 3D Spheroids

Ramsey Foty

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)

Review Biochemistry & Molecular Biology

Transforming growth factor beta (TGF-β) and inflammation in cancer

Brian Bierie et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2010)

Article Otorhinolaryngology

Immune Response During Therapy With Cisplatin or Radiation for Human Papillomavirus-Related Head and Neck Cancer

William C. Spanos et al.

ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2009)

Review Oncology

The role of myeloid cells in the promotion of tumour angiogenesis

Craig Murdoch et al.

NATURE REVIEWS CANCER (2008)

Review Biochemistry & Molecular Biology

TGF-β and cancer

B Bierie et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2006)

Review Oncology

Distinct role of macrophages in different tumor microenvironments

CE Lewis et al.

CANCER RESEARCH (2006)

Review Cell Biology

Mechanisms of TGF-beta-mediated apoptosis

N Schuster et al.

CELL AND TISSUE RESEARCH (2002)

Article Cell Biology

TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase

CW Jang et al.

NATURE CELL BIOLOGY (2002)